Xiayang Ren

4PUBLICATIONS
0CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 11, 2024
Adverse reactions of immune checkpoint inhibitors combined with angiogenesis inhibitors: A pharmacovigilance analysis of drug-drug interactions.

Xiayang Ren, Lei Deng, Xin Dong

|Aug 13, 2024
Cardiovascular toxicities of selective ret-specific tyrosine kinase inhibitors: a pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database.

Yinjing Hou, Xiayang Ren, Ying Chen

|Jul 05, 2024
PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database.

Xiayang Ren, Ping Sun, Yanfeng Wang

|Dec 24, 2022
Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database.

Xiayang Ren, Cilin Yan, Le Tian

Pageof 1

Frequent Collaborators